Regulation of endocytosis into human brain-microvascular endothelial cells by inhibition of efflux proteins

Colloids and Surfaces B: Biointerfaces

Volumn 87, Issue 1, 2011, Pages 139-145

  Kuo, Yung Chih ^a   Lu, Chin Hsun ^a  

^a NATIONAL CHUNG CHENG UNIVERSITY   (Taiwan)

Author keywords

Blood brain barrier; Endocytosis; Multidrug resistance associated protein; P glycoprotein; Tight junction

Indexed keywords

BLOOD-BRAIN BARRIER; ENDOCYTOSIS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN; P-GLYCOPROTEIN; TIGHT JUNCTIONS;

BLOOD; BLOOD VESSELS; BRAIN; CELL CULTURE; GLYCOPROTEINS; MOLECULAR BIOLOGY; MONOLAYERS; PROTEINS;

ENDOTHELIAL CELLS;

CALCEIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN; PROBENECID; VERAPAMIL;

ANIMAL CELL; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CELL CULTURE; CELL DENSITY; CELL SURFACE; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY TEST; DRUG MECHANISM; ENDOCYTOSIS; HUMAN; HUMAN CELL; IMMUNOCHEMISTRY; IN VITRO STUDY; MEMBRANE TRANSPORT; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

BLOOD-BRAIN BARRIER; BRAIN; CELL DEATH; CELL SURVIVAL; ENDOCYTOSIS; ENDOTHELIAL CELLS; FLUORESCEINS; HUMANS; MICROVESSELS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; P-GLYCOPROTEIN; PROBENECID; TIGHT JUNCTIONS; VERAPAMIL;

EID: 79959341901     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.05.014     Document Type: Article

References (38)

1. Pardridge W.M. The blood-brain barrier: bottleneck in brain drug development. J. Am. Soc. Exp. Neurother. 2005, 2:3-14.
2. Kuo Y.C., Chung C.Y. Transport of zidovudine- and lamivudine-loaded polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate nanoparticles across the in vitro blood-brain barrier: characteristics of the drug-delivery system. J. Chin. Inst. Chem. Eng. 2005, 36:627-638.
3. Abbott N.J. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem. Int. 2004, 45:545-552.
4. Begley D.J. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol. Ther. 2004, 104:29-45.
5. Kuo Y.C., Chen H.H. Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. Int. J. Pharm. 2009, 365:206-213.
6. Kreuter J. Application of nanoparticles for the delivery of drugs to the brain. Int. Congr. Ser. 2005, 1277:85-94.
7. Kuo Y.C., Kuo C.Y. Electromagnetic interference in the permeability of saquinavir across the blood-brain barrier using nanoparticulate carriers. Int. J. Pharm. 2008, 351:271-281.
8. Hawkin B.T., Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 2005, 57:173-185.
9. Kuo Y.C., Chen H.H. Effect of nanoparticulate polybutylcyanoacrylate and methylmethacrylate-sulfopropylmethacrylate on the permeability of zidovudine and lamivudine across the in vitro blood-brain barrier. Int. J. Pharm. 2006, 327:160-169.
10. Yu A.S., McCarthy K.M., Francis S.A., McCormack J.M., Lai J., Rogers R.A., Lynch R.D., Schneeberger E.E. Knockdown of occludin expression leads to diverse phenotypic alterations in epithelial cells. Am. J. Physiol. Cell Physiol. 2005, 288:1231-1241.
11. Deeken J.F., Löscher W. The blood-brain barrier and cancer: transporters, treatment, and trojan horses. Clin. Cancer Res. 2007, 13:1663-1674.
12. Nakagawa S., Deli M.A., Nakao S., Honda M., Hayashi K., Nakaoke R., Kataoka Y., Niwa M. Pericytes from brain microvessels strengthen the barrier integrity in primary cultures of rat brain endothelial cells. Cell. Mol. Neurobiol. 2007, 27:687-694.
13. Tanobe K., Nishikawa K., Hinohara H., Okamoto T., Saito S., Masui G.F. Blood-brain barrier and general anesthetics. Jpn. J. Anesthesiol. 2003, 52:840-845.
14. Abbott N.J., Ronnback L., Hannson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7:41-53.
15. Terasaki T., Ohtsuki S., Hori S., Takanaga H., Nakashima E., Hosoya K. New approaches to in vitro models of blood-brain barrier drug transport. Drug Discov. Today 2003, 8:944-954.
16. Kuo Y.C., Chen I.C. Evaluation of surface charge density and surface potential by electrophoretic mobility for solid lipid nanoparticles and human brain-microvascular endothelial cells. J. Phys. Chem. B 2007, 111:11228-11236.
17. Kuo Y.C., Lu C.H. Effect of human astrocytes on the characteristics of human brain-microvascular endothelial cells in the blood-brain barrier. Colloids Surf. B 2011, 86:225-231.
18. Abbott N.J., Patabendige A.A., Dolman D.E., Yusof S.R., Begley D.J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 2010, 37:13-25.
19. Abbott N.J. Physiology of the blood-brain barrier and its consequences for drug transport to the brain. Int. Congr. Ser. 2005, 1277:3-18.
20. Kuo Y.C., Chen H.H. Effect of electromagnetic field on endocytosis of cationic solid lipid nanoparticles by human brain-microvascular endothelial cells. J. Drug Target. 2010, 18:447-456.
21. Kuo Y.C., Su F.L. Transport of stavudine, delavirdine, and saquinavir across the blood-brain barrier by polybutylcyanoacrylate, methylmethacrylate-sulfopropylmethacrylate, and solid lipid nanoparticles. Int. J. Pharm. 2007, 340:143-152.
22. Gaillard P.J., Boer A.G. Relationship between permeability status of the blood-brain barrier and in vitro permeability coefficient of a drug. Eur. J. Pharm. Sci. 2000, 12:95-102.
23. Wolburg H., Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vasc. Pharmacol. 2002, 38:323-337.
24. Rubin L.L., Staddon J.M. The cell biology of blood-brain barrier. Annu. Rev. Neurosci. 1999, 22:11-28.
25. Schinkel A.H. P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv. Drug Deliv. Rev. 1999, 36:179-194.
26. McAllister M.S., Krizanac-Bengez L., Macchia F., Naftalin R.J., Pedley K.C., Mayberg M.R., Marroni M., Leaman S., Stanness K.A., Janigro D. Mechanisms of glucose transport at the blood-brain barrier: an in vitro study. Brain Res. 2001, 904:20-30.
27. Kuo Y.C., Chung J.F. Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers. Colloids Surf. B 2011, 83:299-306.
28. Mazzini A., Incerti M., Favilla R. Interaction of DAPI with pepsin as a function of pH. Biophys. Chem. 1997, 67:65-74.
29. Wilson W.D., Tanious F.A., Barton H.J., Jones R.L., Fox K., Wydra R.L., Strekowski L. DNA sequence dependent binding modes of 4′,6-diamino-2-phenylindole (DAPI). Biochemistry 1990, 29:8452-8461.
30. Decleves X., Regina A., Laplanche J.L., Roux F., Boval B., Launay J.M., Scherrmann J.M. Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes. J. Neurosci. Res. 2000, 60:594-601.
31. Sobue K., Yamamoto N., Yoneda K., Hodgson M.E., Yamashiro K., Tsuruoka N., Tsuda T., Katsuya H., Miura Y., Asai K., Kato T. Induction of blood-brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors. Neurosci. Res. 1999, 35:155-164.
32. Prat A., Biernacki K., Wosik K., Antel J.P. Glial cell influence on the human blood-brain barrier. Glia 2001, 36:145-155.
33. Fujita T., Yamada H., Fukuzumi M., Nishimaki A., Yamamoto A., Muranishi S. Calcein is excreted from the intestinal mucosal cell membrane by the active transport system. Life Sci. 1997, 60:307-313.
34. Limtrakul P., Chearwae W., Shukla S., Phisalphong C., Ambudkar S.V. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin. Mol. Cell. Biochem. 2007, 296:85-95.
35. Kuo Y.C., Liang C.T. Inhibition of human brain malignant glioblastoma cells using carmustine-loaded catanionic solid lipid nanoparticles with surface anti-epithelial growth factor receptor. Biomaterials 2011, 32:3340-3350.
36. Gibbs J.P., Adeyeye M.C., Yang Z., Shen D.D. Valproic acid uptake by bovine brain microvessel endothelial cells: role of active efflux transport. Epilepsy Res. 2004, 58:53-66.
37. Anderle P., Niederer E., Rubas W., Hilgendorf C., Spahn-Langguth H., Wunderli-Allenspach H., Merkle H.P., Langguth P. P-glycoprotein (P-gp) mediated efflux in Caco-2 cell monolayers: the influence of culturing conditions and drug exposure on P-gp expression levels. J. Pharm. Sci. 1998, 87:757-762.
38. Loe D.W., Deeley R.G., Cole S.P.C. Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1). J. Pharmacol. Exp. Ther. 2002, 293:530-538.